The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in SOFA score D0 to SOFA Score D7 (or after last ARTICE® treatment, if later as D7).
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in general SOFA score and SOFA sub scores.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in standard lab and inflammatory biomarkers.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Hospital survival rates.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Apache II Score.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Length of ICU stay (days).
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Mechanical ventilation days.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Renal replacement therapy days.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Vasopressor therapy days.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Frequency of secondary infections.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Type of secondary infections: it will be divided into viral, bacterial or fungi infection.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in the physiological parameter heartrate.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in physiological parameter blood pressure.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in physiological parameter body temperature.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Changes in physiological parameter mean arterial pressure.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.
Complications related to the ARTICE® therapy application.
Timeframe: From enrollment up to 7 days after last ARTICE® treatment.